top of page

Galápagos CEO Paul Stoffels on the company's $3.8B cash balance and decentralized CAR-T program

Paul Stoffels describes how his company's decentralized CAR-T process is designed to have a shorter 'brain-to-vein' time, and he comments on the company's substantial cash balance.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

SAV_Logo_2024.png

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

bottom of page